Don't miss out on your morning cup of coffee: It can lower risk of liver cancer
The risk of hepatocellular carcinoma was low in people who drank mostly instant coffee.
Maintain oral health: Painful gums, mouth ulcers can increase risk of liver cancer
Poor oral hygiene can also result due to chronic problems ...
Good news for aspirin users: Regular use may cut liver cancer risk
Regular use of aspirin is defined as taking two or more standard-dose tabl...
Natco Pharma's partner MylanInc gets USFDA nod for cancer drug
The company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
Parents, watch what your kids eat! Soft drinks, biscuits may increase risk of liver disease
Foods with high fructose levels such as pizzas, and sodas are one of the fastest growing causes of lives ailments.
Hetero gets DCGI approval to market Hepatitis C drug
Hetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
Natco Pharma's US partner Mylan files application with USFDA
Natco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly for treatment of liver and kidney cancers.
Prioritize anti-cancer drive: WHO to India
Concerned at the increasing number of cancer-related deaths, the WHO has suggested prioritizing cancer programmes to deal with the menace.
New medicine for Hepatitis C treatment launched
During the conference, two new drugs were launched for treatment of Hepatitis C disease at affordable price.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service